Emerging therapeutic targets in caspase-dependent disease

By McBride C.B.   McPhail L.T.   Steeves J.D.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 391-411

Informa Healthcare

Access to resources Recommend Favorite

Nitric Oxide-Dependent Neovascularization Role in the Lower Extremity Disease

By  

Current Pharmaceutical Design, Vol. 13, Iss. 35, 2007-12 ,pp. : 3591-3596

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutic targets in diabetic vascular disease

By Schmidt A.M.   Stern D.M.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 483-493

Informa Healthcare

Access to resources Recommend Favorite

Nitric oxide scavengers as a therapeutic approach to nitric oxide mediated disease

By Fricker S.P.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1209-1222

Informa Healthcare

Access to resources Recommend Favorite

Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase

By Severina I.S.   Bussygina O.G.   Pyatakova N.V.   Khropov Y.V.   Krasnoperov R.A.  

European Journal of Pharmacology, Vol. 407, Iss. 1, 2000-10 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite